METROPOLIS HEALTHCARE LIMITED Financials Metropolis Healthcare Limited
Equities
METROPOLIS
INE112L01020
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,054 INR | -0.23% |
|
+0.77% | +22.37% |
| Jul. 09 | Metropolis Healthcare Clocks 13% Increase in Fiscal Q1 Overall Revenue | MT |
| May. 22 | Metropolis Healthcare Limited to Seek Acquisitions | CI |
Valuation
| Fiscal Period: Marzo | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 65,032 | 114,563 | 104,174 | 63,926 | 105,201 | - | - |
| Enterprise Value (EV) 1 | 62,802 | 110,283 | 104,952 | 63,654 | 87,582 | 102,832 | 100,899 |
| P/E ratio | 50.9 x | 62.6 x | 48.9 x | 44.9 x | 69.3 x | 59 x | 46.4 x |
| Yield | 0.62% | 0.36% | 0.39% | 0.64% | 0.47% | 0.53% | 0.67% |
| Capitalization / Revenue | 7.59 x | 11.5 x | 8.48 x | 5.57 x | 7.31 x | 7.77 x | 6.82 x |
| EV / Revenue | 7.33 x | 11.1 x | 8.54 x | 5.54 x | 7.25 x | 7.59 x | 6.55 x |
| EV / EBITDA | 27 x | 38.6 x | 30.6 x | 22.1 x | 31 x | 30 x | 24.8 x |
| EV / FCF | 33.8 x | 49.9 x | 47.1 x | 32.7 x | 43.7 x | 43.5 x | 34.8 x |
| FCF Yield | 2.96% | 2% | 2.12% | 3.05% | 2.29% | 2.3% | 2.87% |
| Price to Book | 12.4 x | 16.2 x | 11.8 x | 6.47 x | 8.05 x | 8.64 x | 7.66 x |
| Nbr of stocks (in thousands) | 50,631 | 51,117 | 51,172 | 51,211 | 51,229 | - | - |
| Reference price 2 | 1,284 | 2,241 | 2,036 | 1,248 | 2,054 | 2,054 | 2,054 |
| Announcement Date | 5/29/20 | 5/27/21 | 5/24/22 | 5/16/23 | 5/21/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 7,694 | 8,564 | 9,980 | 12,283 | 11,482 | 12,077 | 13,544 | 15,414 |
| EBITDA 1 | 2,086 | 2,328 | 2,860 | 3,428 | 2,883 | 2,826 | 3,426 | 4,063 |
| EBIT 1 | - | 1,685 | 2,401 | 2,796 | 1,991 | 1,881 | 2,434 | 2,989 |
| Operating Margin | - | 19.68% | 24.05% | 22.76% | 17.34% | 15.58% | 17.97% | 19.39% |
| Earnings before Tax (EBT) 1 | - | 1,687 | 2,443 | 2,934 | 1,875 | 1,747 | 2,381 | 3,061 |
| Net income 1 | - | 1,273 | 1,831 | 2,142 | 1,429 | 1,278 | 1,767 | 2,265 |
| Net margin | - | 14.87% | 18.35% | 17.44% | 12.44% | 10.58% | 13.04% | 14.69% |
| EPS 2 | 24.02 | 25.25 | 35.79 | 41.66 | 27.81 | 24.87 | 34.81 | 44.26 |
| Free Cash Flow 1 | - | 1,858 | 2,208 | 2,226 | 1,945 | 2,003 | 2,363 | 2,898 |
| FCF margin | - | 21.7% | 22.13% | 18.12% | 16.94% | 16.59% | 17.45% | 18.8% |
| FCF Conversion (EBITDA) | - | 79.81% | 77.22% | 64.94% | 67.45% | 70.89% | 68.99% | 71.33% |
| FCF Conversion (Net income) | - | 145.94% | 120.62% | 103.94% | 136.1% | 156.72% | 133.77% | 127.96% |
| Dividend per Share 2 | 13.26 | 8.000 | 8.000 | 8.000 | 8.000 | 9.753 | 10.83 | 13.73 |
| Announcement Date | 5/13/19 | 5/29/20 | 5/27/21 | 5/24/22 | 5/16/23 | 5/21/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,748 | 2,917 | 3,268 | 3,026 | 2,931 | 3,059 | 2,799 | 3,003 | 2,855 | 2,825 | 2,771 | 3,059 | 2,932 | 3,052 | 3,137 |
| EBITDA 1 | 866.4 | 963.9 | 1,024 | 902.4 | 753.3 | 748.5 | 684.9 | 790.3 | 704.9 | 702.9 | 629.4 | 769.6 | 709.6 | 753.6 | 758.9 |
| EBIT 1 | 756.7 | 823.1 | 890.6 | 752 | 584.4 | 568.6 | 473.2 | 574.5 | 474.6 | 468.5 | 421.2 | 545.2 | 489.9 | 509.2 | 500.4 |
| Operating Margin | 27.54% | 28.21% | 27.26% | 24.85% | 19.94% | 18.59% | 16.91% | 19.13% | 16.63% | 16.58% | 15.2% | 17.82% | 16.71% | 16.68% | 15.95% |
| Earnings before Tax (EBT) 1 | 777.7 | 816.5 | 1,031 | 777.1 | 560.9 | 564.7 | 428.3 | 548 | 479.7 | - | 391.9 | 511.3 | 451.5 | 510.2 | 484.7 |
| Net income 1 | 585.7 | 613.5 | 748.9 | 582.7 | 410.4 | 399.9 | 334 | 403.3 | 358 | 333.6 | 289.8 | 390.8 | 336.4 | 382 | 376.9 |
| Net margin | 21.32% | 21.03% | 22.92% | 19.25% | 14% | 13.07% | 11.93% | 13.43% | 12.54% | 11.81% | 10.46% | 12.78% | 11.47% | 12.51% | 12.01% |
| EPS 2 | 11.46 | 11.99 | 14.58 | 11.34 | 7.980 | 7.780 | 6.490 | 7.850 | 6.970 | 6.490 | 5.610 | 7.592 | 6.872 | 7.207 | 7.244 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/10/21 | 5/27/21 | 8/6/21 | 11/10/21 | 2/11/22 | 5/24/22 | 8/10/22 | 11/8/22 | 2/10/23 | 5/16/23 | 8/2/23 | - | - | - | - |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 779 | - | - | - | - |
| Net Cash position 1 | - | 2,230 | 4,280 | - | 272 | 712 | 2,369 | 4,302 |
| Leverage (Debt/EBITDA) | - | - | - | 0.2271 x | - | - | - | - |
| Free Cash Flow 1 | - | 1,858 | 2,208 | 2,226 | 1,945 | 2,003 | 2,363 | 2,898 |
| ROE (net income / shareholders' equity) | - | 31% | 29.8% | 26.9% | 15.2% | 12.3% | 15.7% | 17.7% |
| ROA (Net income/ Total Assets) | - | - | 20.8% | 16.9% | 9.43% | - | - | - |
| Assets 1 | - | - | 8,783 | 12,674 | 15,160 | - | - | - |
| Book Value Per Share 2 | - | 103.0 | 138.0 | 173.0 | 193.0 | 214.0 | 238.0 | 268.0 |
| Cash Flow per Share 2 | 18.00 | - | 48.70 | 49.30 | 48.10 | 51.40 | 58.20 | 65.20 |
| Capex 1 | 196 | 292 | 282 | 307 | 526 | 638 | 526 | 472 |
| Capex / Sales | 2.54% | 3.41% | 2.82% | 2.5% | 4.58% | 5.28% | 3.89% | 3.06% |
| Announcement Date | 5/13/19 | 5/29/20 | 5/27/21 | 5/24/22 | 5/16/23 | 5/21/24 | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
2,054
INR
Average target price
1,933
INR
Spread / Average Target
-5.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.37% | 1.26B | |
| -18.02% | 8.58B | |
| +76.62% | 4.54B | |
| +14.48% | 2.94B | |
| -3.15% | 2.65B | |
| -8.59% | 1.89B | |
| -53.65% | 1.86B | |
| -13.64% | 1.56B | |
| -46.33% | 1.09B | |
| +16.04% | 963M |
- Stock Market
- Equities
- METROPOLIS Stock
- Financials Metropolis Healthcare Limited
